Sotio
Prague · Founded 2010
About Sotio
Sotio is an international biotechnology company leading the efforts of PPF Group to build a diverse biotechnology portfolio through its own research & development, collaborations, in-licensing, investments, mergers, and acquisitions. The company is developing new medical therapies, focusing on the treatment of cancer and autoimmune diseases. The most advanced project is the SOTIO proprietary platform of active cellular immunotherapy (ACI) based on dendritic cells.
Company Facts
- Founded: 2010
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $316.9M
- Funding stage: Private Equity
- Last round: Series Unknown (Dec 2021)
- Website: sotio.com
- Phone: 420 224 175 111
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sotio-2015 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.